Characterizing RAPIDTM platelet and leukocyte-rich plasma gels - an autologous, point-of-care medicine for diabetic foot ulcer treatment
In 2017/18 wound healing cost the NHS 8.3 billion pounds. There is an urgent need for more effective, accessible, and safe treatments. Platelet-rich plasma (PRP) therapies have been emerging since the early 2000s, currently they are used across various medical fields treating conditions from cosmeti...
Saved in:
Main Authors: | Aleksandra Olszewska (Author), Simon Pitchford (Author), James Rickard (Author), Ben Forbes (Author) |
---|---|
Format: | Book |
Published: |
University of Huddersfield Press,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Production cost of autologous platelet rich plasma gel
by: Andrea Pinto Leite Ribeiro, et al.
Published: (2019) -
Autologous platelet-rich gel treatment of chronic nonhealing ulcerated tophaceous gout
by: Dawei Chen, et al.
Published: (2020) -
The Potential of Autologous Platelet-Rich Plasma Gel for Diabetic Foot Ulcer Care Among Older Adults: A Systematic Review and Meta-Analysis
by: Platini H, et al.
Published: (2024) -
Effectiveness of Autologous Platelet-Rich Plasma for the Healing of Ulcers after Endoscopic Submucosal Dissection
by: Eunju Jeong, et al.
Published: (2019) -
The Effect of Platelet Rich Plasma Dressing on Healing Diabetic Foot Ulcers
by: Karimi, et al.
Published: (2016)